Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

Tufts University scientists are aiming to revolutionize the future of weight loss drugs by engineering a new compound that ...

GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...

A final-stage clinical trial comparing a new long-acting, once-weekly pill to treat schizophrenia symptoms with the existing daily treatment has found that both produce comparable therapeutic effects.

Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

In breakthrough, Hebrew University researchers say painkiller, in use since the 1950s, acts like a local anesthetic; research ...

Researchers at Rutgers University-New Brunswick (N.J.) are questioning the FDA’s 2020 decision to place a safety warning on a common antiseizure medication. Lamictal (lamotrigine), a GSK medicine ...

The best time to take melatonin is 30 minutes to one hour before your desired bedtime. Learn more about the best time to take ...

A new study has found a significant association between the use of GLP-1s such as Ozempic and Wegovy with a higher risk of developing a serious eye condition in patients with diabetes. Here are four t ...

For many patients with schizophrenia, other psychiatric illnesses, or diseases such as hypertension and asthma, it can be ...

The TEASE-1 trial reveals gildeuretinol's potential to reduce vision loss in Stargardt disease, offering hope for future treatments.

The regulator has set a timeframe of 12th August for its review of the new drug application (NDA ... positive phase 2 data in the Tailwind study – along with Boehringer Ingelheim's cathepsin ...